BioMarin Announces Fourth Quarter and Record Full-year 2020 Financial Results and Corporate Updates

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. MU
6. FDX
7. IBM
8. PRIM
9. PFE
10. AWK

Go back to BioMarin Announces Fourth Quarter and Record Full-year 2020 Financial Results and Corporate Updates

BioMarin Pharma (BMRN) Tops Q4 EPS by 31c

February 25, 2021 4:19 PM EST

BioMarin Pharma (NASDAQ: BMRN) reported Q4 EPS of $0.12, $0.31 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $452.1 million versus the consensus estimate of $440.23 million.

GUIDANCE:

BioMarin Pharma sees FY2021 revenue of $1.75-1.85 billion, versus the consensus of $1.91... More